1. Kim Y, Johnson TW, Jeong MH. Potent P2Y12 receptor inhibition in Korean patients with acute myocardial infarction. Korean Circ J. 2019; 49:1199–1200.
2. Yun KH, Cho JY, Rhee SJ, Oh SK. Temporal variability of platelet reactivity in patients treated with clopidogrel or ticagrelor. Korean Circ J. 2019; 49:1052–1061.
3. Park DW, Kwon O, Jang JS, et al. Clinically significant bleeding with ticagrelor versus clopidogrel in Korean patients with acute coronary syndromes intended for invasive management: a randomized clinical trial. Circulation. 2019; [Epub ahead of print].
4. Yun JE, Kim YJ, Park JJ, et al. Safety and effectiveness of contemporary P2Y12 inhibitors in an East Asian population with acute coronary syndrome: a nationwide population-based cohort study. J Am Heart Assoc. 2019; 8:e012078.